Prostate cancer (PCa) diagnosis using prostate-specific antigen (PSA) and transperineal ultrasound-guided biopsies combined with multiparametric magnetic resonance imaging (mpMRI) is recommended by the European guidelines [1] and common practice. Here, KLK3 is linked to prostate cancer.